AT300217B - Verfahren zur Herstellung von neuen 21,21-Dichlorsteroiden - Google Patents

Verfahren zur Herstellung von neuen 21,21-Dichlorsteroiden

Info

Publication number
AT300217B
AT300217B AT598070A AT598070A AT300217B AT 300217 B AT300217 B AT 300217B AT 598070 A AT598070 A AT 598070A AT 598070 A AT598070 A AT 598070A AT 300217 B AT300217 B AT 300217B
Authority
AT
Austria
Prior art keywords
steroids
dichloro
new
production
dichloro steroids
Prior art date
Application number
AT598070A
Other languages
English (en)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of AT300217B publication Critical patent/AT300217B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT598070A 1969-07-24 1970-07-02 Verfahren zur Herstellung von neuen 21,21-Dichlorsteroiden AT300217B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1938218A DE1938218C3 (de) 1969-07-24 1969-07-24 9 a,21,21-Trichlor-ll ß-fluor- pregnene, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
AT300217B true AT300217B (de) 1972-07-25

Family

ID=5741103

Family Applications (1)

Application Number Title Priority Date Filing Date
AT598070A AT300217B (de) 1969-07-24 1970-07-02 Verfahren zur Herstellung von neuen 21,21-Dichlorsteroiden

Country Status (18)

Country Link
US (1) US3681405A (de)
JP (1) JPS4815290B1 (de)
AT (1) AT300217B (de)
BE (1) BE753874A (de)
CH (1) CH557339A (de)
CS (1) CS161757B2 (de)
DE (1) DE1938218C3 (de)
DK (1) DK122454B (de)
ES (1) ES381790A1 (de)
FI (1) FI46844C (de)
FR (1) FR2059554B1 (de)
GB (1) GB1317194A (de)
IE (1) IE34401B1 (de)
IL (1) IL34976A (de)
NL (1) NL7010876A (de)
PL (1) PL79781B1 (de)
SE (1) SE355578B (de)
ZA (1) ZA704574B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
ES2744879T3 (es) 2008-05-28 2020-02-26 Reveragen Biopharma Inc Moduladores esteroideos no hormonales de NF-kappaB para el tratamiento de enfermedades
WO2011127048A2 (en) 2010-04-05 2011-10-13 Validus Biopharma NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3236866A (en) * 1959-04-08 1966-02-22 Syntex Corp 21, 21-difluoro pregnenes
US3025312A (en) * 1959-07-14 1962-03-13 Olin Mathieson 9alpha, 11beta-dichloro pregnanes
US3038898A (en) * 1960-11-10 1962-06-12 Syntex Sa 6-fluoromethyl-9alpha, 11beta-dichlorocortical hormones

Also Published As

Publication number Publication date
SE355578B (de) 1973-04-30
JPS4815290B1 (de) 1973-05-14
US3681405A (en) 1972-08-01
IE34401B1 (en) 1975-04-30
CH557339A (de) 1974-12-31
FR2059554A1 (de) 1971-06-04
DE1938218C3 (de) 1978-10-19
FI46844C (fi) 1973-07-10
GB1317194A (en) 1973-05-16
FR2059554B1 (de) 1974-06-14
CS161757B2 (de) 1975-06-10
IE34401L (en) 1971-01-24
PL79781B1 (de) 1975-06-30
ES381790A1 (es) 1972-12-01
IL34976A0 (en) 1970-09-17
IL34976A (en) 1973-06-29
DK122454B (da) 1972-03-06
BE753874A (fr) 1971-01-25
DE1938218B2 (de) 1978-01-26
DE1938218A1 (de) 1971-02-04
ZA704574B (en) 1971-03-31
FI46844B (de) 1973-04-02
NL7010876A (de) 1971-01-26

Similar Documents

Publication Publication Date Title
AT303057B (de) Verfahren zur Herstellung von neuen Ureidophenylguanidinen
AT305994B (de) Verfahren zur Herstellung von neuen 5-Nitrofuranderivaten
CH547793A (de) Verfahren zur herstellung von neuen evomonosid-derivaten.
AT300821B (de) Verfahren zur Herstellung von neuen Phenomorpholinen
CH540250A (de) Verfahren zur Herstellung von neuen Halogensulfonamiden
AT300217B (de) Verfahren zur Herstellung von neuen 21,21-Dichlorsteroiden
AT304495B (de) Verfahren zur Herstellung von neuen 9,10-Dihydro-9,10-äthano-anthrazenen
CH547346A (de) Verfahren zur herstellung von neuen riechstoffen.
AT304511B (de) Verfahren zur Herstellung von neuen 9,10-Dihydro-9,10-ätheno-anthracenen
AT301769B (de) Verfahren zur Herstellung von neuen 21-Halogensteroiden
AT308292B (de) Verfahren zur Herstellung von neuen Steroiden
AT298465B (de) Verfahren zur Herstellung von neuen, substituierten o-Anilino-phenäthylalkoholen
CH549582A (de) Verfahren zur herstellung von neuen tetrahydro-benzodiazepinonen.
AT293384B (de) Verfahren zur Herstellung von neuen Ketonitrilen
CH539626A (de) Verfahren zur Herstellung von neuen 21-Halogensteroiden
AT303982B (de) Verfahren zur Herstellung von neuen 7α-Methyl-1α,2α-methylen-androstenolonen
CH539027A (de) Verfahren zur Herstellung von neuen Steroidverbindungen
AT296515B (de) Verfahren zur Herstellung von neuen basischen 2-Androsten-17-äthern
AT313494B (de) Verfahren zur herstellung von neuen 16-methylen-9beta,10 alpha-steroiden
AT300206B (de) Verfahren zur Herstellung von neuen 6,7-Benzomorphanen
AT301052B (de) Verfahren zur Herstellung von neuen 20,20-Äthylen-21-oxo-steroiden
AT301046B (de) Verfahren zur Herstellung von neuen Cardenolid-geninen
AT290024B (de) Verfahren zur Herstellung von neuen, ungesättigten Aminosteroiden
AT299143B (de) Verfahren zur Herstellung von neuen Nitrosaminalen
AT304775B (de) Verfahren zur Herstellung von neuen 2-Chlor-δ<1,4>-steroiden

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee